Net Medical Partners With BioVentive to Market Telemedicine Services Nationally

ALBUQUERQUE, NM--(Marketwired - Aug 4, 2015) - Net Medical Xpress Solutions, Inc. (OTCQB: NMXS), a leader in the telemedicine field, announced today that it is partnering with BioVentive to market telemedicine services to the healthcare industry throughout the United States.

Over 100 sales representatives will market telemedicine products and services from BioVentive based on Net Medical technology and exclusive products and services from Net Medical, including the company's Specialist Services as well as new BioVentive products based on Net Medical technology.

Brett Nauta, CEO of BioVentive, said, "We are extremely pleased to partner with Net Medical Xpress to develop new products and markets for healthcare communications. Our management team believes the proprietary Net Medical technology platform offers expansion capabilities that can open new markets and solve the growing need for better access to quality healthcare. We selected Net Medical based on their proven experience using emerging medical communications technologies to provide high quality service to their customers. Their team's overwhelming emphasis and concern for positive patient outcomes was an important factor for us."

Dick Govatski, CEO, Net Medical, said, "This is an exciting and significant expansion of our telemedicine activities in all 50 states. Net Medical will benefit several ways including revenue streams from new products created by BioVentive, the geographical expansion of marketing and sales of our successful hospital telemedicine program, and the sale of our proprietary telemedicine carts for use in these various services. We are delighted to partner with a company with the experience and expertise of BioVentive."

About BioVentive
BioVentive, Inc. is a private consultative sales and marketing company based in California that provides sales and service capabilities for healthcare organizations with a focus on emerging healthcare technologies and next generation genetic testing products. To learn more go to: http://www.bioventive.com

About Net Medical Xpress Solutions, Inc:
Net Medical Xpress is a multi-faceted telemedicine company with four operating segments. The company has over 436 physicians under contract and offices in three cities in the U.S. Net Medical successfully completed 400,000 telemedicine cases in 2014 The company provides telemedicine programs for diagnostic and clinical medical services to mobile companies, urgent cares, hospitals, trauma centers, imaging centers, jails, nursing homes, corporate health departments and out patient medical facilities. The company's proprietary, web-based technology is the platform that enables medical providers to make real-time assessments of patients' conditions and treatment needs.

For more information, visit www.netmedical.com or www.nmxs.com or contact Dick Govatski, president and CEO, at 505-255-1999 or ceo@nmxs.com.

An investment profile for Net Medical Xpress is available online at http://www.hawkassociates.com/profile/nmxs.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

For investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 (ceo@nmxs.com).

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.